Search for other papers by Wei Sun in
Google Scholar
PubMed
Search for other papers by Boyuan Zheng in
Google Scholar
PubMed
Search for other papers by Zhihong Wang in
Google Scholar
PubMed
Search for other papers by Wenwu Dong in
Google Scholar
PubMed
Search for other papers by Yuan Qin in
Google Scholar
PubMed
Search for other papers by Hao Zhang in
Google Scholar
PubMed
Introduction The most prevalent endocrine malignancy is thyroid cancer, which accounts for 1% of all malignancies. Recently, morbidity caused by thyroid cancer has increased by three-fold ( 1 , 2 ). Histologically, the most common type of
Search for other papers by Chan Sub Park in
Google Scholar
PubMed
Search for other papers by Jihye Choi in
Google Scholar
PubMed
Search for other papers by Min-Ki Seong in
Google Scholar
PubMed
Search for other papers by Sung-Eun Hong in
Google Scholar
PubMed
Search for other papers by Jae-Sung Kim in
Google Scholar
PubMed
Search for other papers by In-Chul Park in
Google Scholar
PubMed
Search for other papers by Hyesil Seol in
Google Scholar
PubMed
Search for other papers by Woo Chul Noh in
Google Scholar
PubMed
Search for other papers by Hyun-Ah Kim in
Google Scholar
PubMed
Introduction Estradiol is a key factor for tumorigenesis and prognosis of hormone receptor (HR)-positive breast cancer. Although estradiol is produced mainly by the ovary in premenopausal women, the adrenal gland and adipocytes are also
Faculty of Medicine, The University of Sydney, Sydney, Australia
Search for other papers by Ayanthi Wijewardene in
Google Scholar
PubMed
Faculty of Medicine, The University of Sydney, Sydney, Australia
Search for other papers by Matti Gild in
Google Scholar
PubMed
Faculty of Medicine, The University of Sydney, Sydney, Australia
Search for other papers by Lyndal Tacon in
Google Scholar
PubMed
Faculty of Medicine, The University of Sydney, Sydney, Australia
Search for other papers by Venessa Tsang in
Google Scholar
PubMed
Department of Anatomical Pathology, NSW Health Pathology, Royal North Shore Hospital, Sydney, Australia
Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital, Sydney Australia
Search for other papers by Anthony J Gill in
Google Scholar
PubMed
Department of Endocrine Surgery, Royal North Shore Hospital, Sydney, Australia
Search for other papers by Anthony Robert Glover in
Google Scholar
PubMed
Department of Endocrine Surgery, Royal North Shore Hospital, Sydney, Australia
Search for other papers by Mark Sywak in
Google Scholar
PubMed
Department of Endocrine Surgery, Royal North Shore Hospital, Sydney, Australia
Search for other papers by Stan Sidhu in
Google Scholar
PubMed
Faculty of Medicine, The University of Sydney, Sydney, Australia
Search for other papers by Bruce Robinson in
Google Scholar
PubMed
Department of Nuclear Medicine, Royal North Shore Hospital, Sydney, Australia
Search for other papers by Paul Roach in
Google Scholar
PubMed
Department of Nuclear Medicine, Royal North Shore Hospital, Sydney, Australia
Search for other papers by Geoffrey Schembri in
Google Scholar
PubMed
Department of Nuclear Medicine, Royal North Shore Hospital, Sydney, Australia
Search for other papers by Jeremy Hoang in
Google Scholar
PubMed
Faculty of Medicine, The University of Sydney, Sydney, Australia
Search for other papers by Roderick Clifton-Bligh in
Google Scholar
PubMed
Introduction Radioactive iodine (RAI) is frequently administered in the management of differentiated thyroid cancer (DTC) to reduce the risk of recurrence or treat persistent disease following a total thyroidectomy. The recommendations for RAI
Search for other papers by Izabelle Lövgren in
Google Scholar
PubMed
Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK
Search for other papers by Azadeh Abravan in
Google Scholar
PubMed
Search for other papers by Abigail Bryce-Atkinson in
Google Scholar
PubMed
Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK
Search for other papers by Marcel van Herk in
Google Scholar
PubMed
cancer survivors following cranial irradiation. GH, growth hormone; TSH, thyroid stimulating hormone; LH/FSH, luteinizing and follicle-stimulating hormone; ACTH, adrenocorticoptropin. ‘Photon’ indicates the use of photon-beam RT, and ‘Proton’ refers to
Search for other papers by Changjiao Yan in
Google Scholar
PubMed
Search for other papers by Meiling Huang in
Google Scholar
PubMed
Search for other papers by Xin Li in
Google Scholar
PubMed
Search for other papers by Ting Wang in
Google Scholar
PubMed
Search for other papers by Rui Ling in
Google Scholar
PubMed
Introduction Thyroid cancer, especially papillary subtype, is the most common malignancy in the endocrine system ( 1 ). Papillary thyroid cancer (PTC) can be further classified into conventional variant (CPTC), follicular variant (FVPTC) and
The First Affiliated Hospital, Department of Otorhinolaryngology, Hengyang Medical School, University of South China, Hengyang, Hunan, China
Search for other papers by Zuyao Chen in
Google Scholar
PubMed
The First Affiliated Hospital, Department of Endocrinology and Metabolism, Hengyang Medical School, University of South China, Hengyang, Hunan, China
Search for other papers by Xiaolin Zhong in
Google Scholar
PubMed
Search for other papers by Weiqiang Tang in
Google Scholar
PubMed
Search for other papers by Min Xia in
Google Scholar
PubMed
Search for other papers by Chang Liu in
Google Scholar
PubMed
Search for other papers by Yinping Guo in
Google Scholar
PubMed
Search for other papers by Yan Yi in
Google Scholar
PubMed
Search for other papers by Qingshan Jiang in
Google Scholar
PubMed
Search for other papers by Xuyu Zu in
Google Scholar
PubMed
Search for other papers by Jing Zhong in
Google Scholar
PubMed
. Materials and methods Cell lines The human PTC cell lines (B-CPAP, CTCC-400-0087; TPC-1, CTCC-400-0084), the human thyroid squamous cancer cell line (SW579, CTCC-400-0202), and the human ATC cell line (CAL-62, CTCC-400-0099) were purchased from Meisen
Search for other papers by Guoquan Zhu in
Google Scholar
PubMed
Search for other papers by Yuying Deng in
Google Scholar
PubMed
Search for other papers by Liqin Pan in
Google Scholar
PubMed
Search for other papers by Wei Ouyang in
Google Scholar
PubMed
Search for other papers by Huijuan Feng in
Google Scholar
PubMed
Search for other papers by Juqing Wu in
Google Scholar
PubMed
Search for other papers by Pan Chen in
Google Scholar
PubMed
Search for other papers by Jing Wang in
Google Scholar
PubMed
Search for other papers by Yanying Chen in
Google Scholar
PubMed
Search for other papers by Jiaxin Luo in
Google Scholar
PubMed
Introduction Papillary thyroid cancer (PTC) is a common endocrine malignancy, accounting for approximately 90% of all thyroid cancers. There are several histological variants of PTC, with conventional PTC constituting the majority of cases ( 1
Department of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
Search for other papers by Ayako Sato in
Google Scholar
PubMed
Search for other papers by Katsuya Matsuda in
Google Scholar
PubMed
Search for other papers by Takahiro Motoyama in
Google Scholar
PubMed
Al-Farabi Kazakh National University, Almaty City, Republic of Kazakhstan
Search for other papers by Zhanna Mussazhanova in
Google Scholar
PubMed
Search for other papers by Ryota Otsubo in
Google Scholar
PubMed
Search for other papers by Hisayoshi Kondo in
Google Scholar
PubMed
Search for other papers by Yuko Akazawa in
Google Scholar
PubMed
Search for other papers by Miyoko Higuchi in
Google Scholar
PubMed
Search for other papers by Ayana Suzuki in
Google Scholar
PubMed
Search for other papers by Mitsuyoshi Hirokawa in
Google Scholar
PubMed
Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
Search for other papers by Takeshi Nagayasu in
Google Scholar
PubMed
Search for other papers by Masahiro Nakashima in
Google Scholar
PubMed
tumorigenesis of a diverse cancers, such as thyroid, skin, cervix, bladder, and esophageal carcinomas ( 7 , 8 , 9 , 10 , 11 ). Our more recent study using IF analysis of formalin-fixed paraffin-embedded (FFPE) tissues demonstrated that the number of 53BP1
Search for other papers by Xiaoya Zheng in
Google Scholar
PubMed
Search for other papers by Heng Xiao in
Google Scholar
PubMed
Search for other papers by Jian Long in
Google Scholar
PubMed
Search for other papers by Qiang Wei in
Google Scholar
PubMed
Search for other papers by Liping Liu in
Google Scholar
PubMed
Search for other papers by Liping Zan in
Google Scholar
PubMed
Search for other papers by Wei Ren in
Google Scholar
PubMed
JWM Hurkmans DP Schreurs MWJ Oomen-de Hoop E van der Veldt AAM Bins S Joosse A Koolen SLW Debets R Overt thyroid dysfunction and anti-thyroid antibodies predict response to anti-PD-1 immunotherapy in cancer patients . Thyroid 2020 30
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Search for other papers by Yujie Ren in
Google Scholar
PubMed
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Search for other papers by Xue Han in
Google Scholar
PubMed
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Search for other papers by Yujiang Li in
Google Scholar
PubMed
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Key Laboratory of TCM Syndrome and Treatment of Yingbing (Thyroid Disease) of State Administration of Traditional Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Search for other papers by Guofang Chen in
Google Scholar
PubMed
Search for other papers by Lin Jiang in
Google Scholar
PubMed
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Key Laboratory of TCM Syndrome and Treatment of Yingbing (Thyroid Disease) of State Administration of Traditional Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Search for other papers by Chao Liu in
Google Scholar
PubMed
Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
Search for other papers by Shuhang Xu in
Google Scholar
PubMed
Introduction With the widespread application of ultrasonography in recent decades ( 1 ), the prevalence of thyroid cancer has gradually risen to the 11th and 5th ranks in all cancers and those in women, respectively ( 2 ). Papillary thyroid